Zhejiang Xinan Chemical Industrial Group (600596) Fair Value & Analysis
Basic Materials · CN · Market cap 19.4B CNY
Fair value as of: Jun 24, 2026
Analysis
Zhejiang Xinan Chemical Industrial Group (600596) currently trades at ¥16.55, while our model-based Fair Value estimate is ¥2.68 — implying the stock looks roughly 83.8% overvalued today. We read business quality at 88/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Zhejiang Xinan Chemical Industrial Group Co.,Ltd develops, manufactures, and sells chemical products for plant protection in China and internationally. The company provides crop protection system of seeds and seedlings, herbicides, insecticides, fungicides, crop nutrition and other products; silicon-based materials, such as industrial chain from mining and smelting upstream silicon, organic silicon monomer synthesis and manufacturing downstream products; and phosphorus based new materials, such as phosphorus trichloride, phosphorus oxychloride, TCPP, TEP and other products. Its products are used in power communications, rail transit and automobiles, medical health, consumer electronics, and other fields. Zhejiang Xinan Chemical Industrial Group Co.,Ltd was founded in 1965 and is headquartered in Jiande, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Zhejiang Xinan Chemical Industrial Group (600596) undervalued?
What is the fair value of 600596?
What is the quality score of 600596?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.